Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

47.91
-2.3200-4.62%
Pre-market: 48.050.1400+0.29%08:49 EDT
Volume:7.17M
Turnover:345.99M
Market Cap:5.90B
PE:12.75
High:50.25
Open:50.25
Low:47.50
Close:50.23
Loading ...

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

Zacks
·
27 Jan

ParaZero Gets Approval From Israel's Defense Agency to Market HALO Precision Airdrop System

MT Newswires Live
·
18 Jan

ParaZero Secures Defense Approval for HALO Drone System

TIPRANKS
·
17 Jan

ParaZero Receives Israel Ministry of Defense Approval for of its HALO Precision Airdrop System for Drones

GlobeNewswire
·
17 Jan

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks
·
15 Jan

ParaZero Successfully Tests HALO Precision Airdrop System

TIPRANKS
·
15 Jan

ParaZero announces successful completion of development test for HALO Precision

TIPRANKS
·
15 Jan

ParaZero Announces Successfully Tests HALO Precision Airdrop System for Critical Supply Deliveries

GlobeNewswire
·
15 Jan

Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy

Zacks
·
14 Jan

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

Zacks
·
14 Jan

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

Zacks
·
14 Jan

Halozyme Therapeutics, Inc. : Wells Fargo Cuts Target Price to $57 From $62

THOMSON REUTERS
·
13 Jan

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and SAGE Therapeutics (SAGE)

TIPRANKS
·
13 Jan

Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why

Zacks
·
11 Jan

Halozyme Therapeutics Is Maintained at Neutral by Piper Sandler

Dow Jones
·
11 Jan

SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data

Zacks
·
10 Jan

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks
·
10 Jan

Halozyme Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
10 Jan

Piper Sandler Remains a Hold on Halozyme (HALO)

TIPRANKS
·
10 Jan

HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock Up

Zacks
·
10 Jan